China has unveiled an artificial intelligence platform for drug discovery that can screen a vast library of chemical compounds, cutting the initial drug screening phase from months or years down to tens of seconds.Developers said they expected the system to provide a novel method for identifying lead molecules to treat tumours, neurodegenerative conditions, rare diseases and emerging infectious diseases, as well as possibly speeding up drug research during public health crises.Called GalaxyVS,...